Skip to main content
Clinical Trials/NCT06101797
NCT06101797
Completed
Not Applicable

Remote and In-person Supervised Exercise in Patients With Knee Osteoarthritis (RISE-KOA): a Single Blinded, Randomized, Non-inferiority Trial.

Federal University of Pelotas1 site in 1 country48 target enrollmentDecember 4, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Knee Osteoarthritis
Sponsor
Federal University of Pelotas
Enrollment
48
Locations
1
Primary Endpoint
Pain intensity
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

Exercise supervision via telehealth resources is an alternative to the in-person modality with similar therapeutic effectiveness across different clinical profiles. Especially in the context of knee osteoarthritis (OA), exercise is recommended by international guidelines. However, it is necessary to elucidate the comparability of remote and in-person supervised exercise effectiveness for these patients. Therefore, the study's objective is to investigate the responses of a remote compared to the in-person supervised exercise program on patient-reported outcomes measures (PROMs), muscular architecture, and the functional performance of patients with knee OA. Forty-eight patients with symptomatic and radiographic knee OA will be randomly assigned to remote or in-person exercise programs. The intervention will last 12 weeks, encompassing muscle-strengthening exercises for the lower extremities, with a frequency of twice a week for the initial two weeks and three sessions per week from the third week onwards. Supervision will be conducted remotely via video calls in one group, while the other will receive in-person supervision at a physiotherapy clinic. Program sessions will comprise six exercises. In the first session treatment block, exercises will be guided for the muscle groups of the knee extensors, hip adductors, and plantar flexors, and in the second block, for knee extensors, hip abductors, and knee flexors. After the 12-week supervised treatment period, participants will be encouraged to continue the same exercise program at home without a physiotherapist in the following six weeks. PROMs related to the joint condition will be measured, such as pain, symptoms, daily activities, sports and leisure activities, and quality of life. The psychological domain will also be evaluated, including pain catastrophizing, symptoms of depression, anxiety and stress, and sleep quality. Additionally, measurements of the muscular architecture of the quadriceps femoris, including muscle thickness, pennation angle, fascicle length, and echo intensity, will be taken. Functional performance will be assessed through tests that include the skills of standing and sitting, walking and going up, and down stairs. PROMs will be measured at weeks 0, 6, 12, and 18. Muscular architecture and functional parameters will be measured at weeks 0 and 12. Data analysis will be conducted using Linear Mixed Models, and analysis will be presented by intention to treat and per protocol. The significance level adopted for this study will be α = 0.05.

Registry
clinicaltrials.gov
Start Date
December 4, 2023
End Date
March 8, 2025
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Federal University of Pelotas
Responsible Party
Principal Investigator
Principal Investigator

Cristine Lima Alberton

Principal Investigator

Federal University of Pelotas

Eligibility Criteria

Inclusion Criteria

  • Patients with a radiographic diagnosis of unilateral or bilateral knee OA and classified as grades II or III according to the Kellgren and Lawrence criteria (KELLGREN e LAWRENCE, 1957).
  • Symptomatic patients according to following American College of Rheumatology criteria - average pain score ≥3 in the last week on the numerical rating scale (0-10), morning stiffness \<30 minutes and joint crepitus (ALTMAN et al., 1986).
  • Independent walking and internet access.

Exclusion Criteria

  • Patients with systemic inflammatory diseases, including rheumatoid arthritis, ankylosing spondylitis, and systemic lupus erythematosus.
  • Neurological diseases with motor disability.
  • Unstable heart diseases.
  • History of total knee arthroplasty or lower extremity surgery.
  • Body mass index (BMI) ≥ 35 kg/m².
  • Physical therapy treatment or participation in a supervised exercise program in the last six months.

Outcomes

Primary Outcomes

Pain intensity

Time Frame: Baseline (week 0), During intervention (week 6), Post-intervention (week 12).

Average pain intensity in the last week will be assessed using an 11-point Pain Intensity Numerical Rating Scale (NRS), in which 0 corresponds to "no pain," and 10 represents "worst possible pain." NRS is a patient-reported outcome measure for assessment and clinical decision-making in patients with knee OA with good psychometric properties (ORNETTI et al., 2011).

Physical function

Time Frame: Baseline (week 0), During intervention (week 6), Post-intervention (week 12).

Physical function will be measured by Knee Injury and Osteoarthritis Outcome Score (KOOS) using an Activities of Daily Living subscale. The KOOS is a patient-reported outcome measure composed of 42 items divided into five subscales: Pain, other Symptoms, Activities of daily living, Sport and Recreation Function, and Knee-related Quality of Life. Its score ranges from 0 (extreme problem) to 100 (no problems) separately in each subscale (COLLINS et al., 2011). The Brazilian version of the KOOS questionnaire was recently validated, consisting of an instrument with validity, reliability, and responsiveness in patients with knee OA (ALMEIDA et al., 2022).

Secondary Outcomes

  • Pain intensity(Follow up period (week 18).)
  • Physical function(Follow up period (week 18).)
  • Pain score(Baseline (week 0), During intervention (week 6), Post-intervention (week 12), Follow up period (week 18).)
  • Other Symptoms(Baseline (week 0), During intervention (week 6), Post-intervention (week 12), Follow up period (week 18).)
  • Sport and Recreation Function(Baseline (week 0), During intervention (week 6), Post-intervention (week 12), Follow up period (week 18).)
  • Knee-related Quality of Life(Baseline (week 0), During intervention (week 6), Post-intervention (week 12), Follow up period (week 18).)
  • Pain catastrophizing(Baseline (week 0), During intervention (week 6), Post-intervention (week 12), Follow up period (week 18).)
  • Symptoms of depression, anxiety, and stress(Baseline (week 0), During intervention (week 6), Post-intervention (week 12), Follow up period (week 18).)
  • Sleep quality(Baseline (week 0), During intervention (week 6), Post-intervention (week 12), Follow up period (week 18).)
  • Sit-to-stand activity(Baseline (week 0), and Post-intervention (week 12).)
  • Ambulatory transition activity(Baseline (week 0), and Post-intervention (week 12).)
  • Short distance walking activity(Baseline (week 0), and Post-intervention (week 12).)
  • Stair negotiation activity(Baseline (week 0), and Post-intervention (week 12).)
  • Quadriceps femoris muscle thickness(Baseline (week 0), and Post-intervention (week 12).)
  • Quadriceps femoris muscle quality(Baseline (week 0), and Post-intervention (week 12).)
  • Pennation angle(Baseline (week 0), and Post-intervention (week 12).)
  • Fascicle length(Baseline (week 0), and Post-intervention (week 12).)

Study Sites (1)

Loading locations...

Similar Trials